Non-compliance with colonoscopy after a positive faecal immunochemical test doubles the risk of dying from colorectal cancer

2021/03/31 by Manuel Zorzi, Jessica Battagello, Kevin Selby +6 · 21 citations
Medicine · #Colorectal Cancer Screening and Detection #Genetic factors in colorectal cancer #Microscopic Colitis

paper · pdf · doi:10.1136/gutjnl-2020-322192

Abstract

BACKGROUND: The risk of colorectal cancer (CRC) among subjects with a positive faecal immunochemical test (FIT) who do not undergo a colonoscopy is unknown. We estimated whether non-compliance with colonoscopy after a positive FIT is associated with increased CRC incidence and mortality. METHODS: The FIT-based CRC screening programme in the Veneto region (Italy) invited persons aged 50 to 69 years with a positive FIT (>20 µg Hb/g faeces) for diagnostic colonoscopy at an endoscopic referral centre. In this retrospective cohort study, we compared the 10-year cumulative CRC incidence and mortality among FIT positives who completed a diagnostic colonoscopy within the programme (compliers) and those who did not (non-compliers), using the Kaplan-Meier estimator and Cox-Aalen models. RESULTS: Some 88 013 patients who were FIT positive complied with colonoscopy (males: 56.1%; aged 50-59 years: 49.1%) while 23 410 did not (males: 54.6%; aged 50-59 years: 44.9%).The 10-year cumulative incidence of CRC was 44.7 per 1000 (95% CI, 43.1 to 46.3) among colonoscopy compliers and 54.3 per 1000 (95% CI, 49.9 to 58.7) in non-compliers, while the cumulative mortality for CRC was 6.8 per 1000 (95% CI, 5.9 to 7.6) and 16.0 per 1000 (95% CI, 13.1 to 18.9), respectively. The risk of dying of CRC among non-compliers was 103% higher than among compliers (adjusted HR, 2.03; 95% CI, 1.68 to 2.44). CONCLUSION: The excess risk of CRC death among those not completing colonoscopy after a positive faecal occult blood test should prompt screening programmes to adopt effective interventions to increase compliance in this high-risk population.

Citations

• Colonoscopy later than 270 days in a fecal immunochemical test-based population screening program is associated with higher prevalence of colorectal cancer

Cited by

• Trends of Cancer Screenings, Diagnoses, and Mortalities During the COVID-19 Pandemic: Implications and Future Recommendations
• Positive impact of a faecal-based screening programme on colorectal cancer mortality risk. [europepmc]
• Trends of Cancer Screenings, Diagnoses, and Mortalities During the COVID-19 Pandemic: Implications and Future Recommendations. [europepmc]
• Cost-Effectiveness of Waiving Coinsurance for Follow-Up Colonoscopy after a Positive Stool-Based Colorectal Screening Test in a Medicare Population. [europepmc]
• Robotic, self-propelled, self-steerable, and disposable colonoscopes: Reality or pipe dream? A state of the art review. [europepmc]
• Postponing colonoscopy for 6 months in high-risk population increases colorectal cancer detection in China. [europepmc]
• Joint Asian Pacific Association of Gastroenterology (APAGE)-Asian Pacific Society of Digestive Endoscopy (APSDE) clinical practice guidelines on the use of non-invasive biomarkers for diagnosis of colorectal neoplasia. [europepmc]
• Robotic Colonoscopy and Beyond: Insights into Modern Lower Gastrointestinal Endoscopy. [europepmc]
• Effect of different anesthetic modalities with multimodal analgesia on postoperative pain level in colorectal tumor patients. [europepmc]
• Population-based screening for colorectal cancer in Wuhan, China. [europepmc]
• Commentary: Liquid Biopsy for Average-Risk Colorectal Cancer Screening. [europepmc]
• Trends in colorectal cancer screening compliance and incidence among 60- to 74-year-olds in China. [europepmc]
• 5-Hydroxymethylated Biomarkers in Cell-Free DNA Predict Occult Colorectal Cancer up to 36 Months Before Diagnosis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. [europepmc]
• Development of Electronic Nose as a Complementary Screening Tool for Breath Testing in Colorectal Cancer. [europepmc]
• The Value of Clinical Decision Support in Healthcare: A Focus on Screening and Early Detection. [europepmc]
• Health Policy and Screening for Colorectal Cancer in the United States. [europepmc]
• Comparing the effectiveness of implementation strategies to improve liver and colon cancer screening for Veterans: protocol for a large cluster-randomized implementation study. [europepmc]
• Assessing the impact of a single qualitative fecal immunochemical test on colonoscopy prioritization and mortality in risk-stratified patients with suspected colorectal cancer: a retrospective cohort study. [europepmc]
• Modeled Cost-Effectiveness of a Rideshare Program to Facilitate Colonoscopy Completion. [europepmc]
• Effectiveness and cost-effectiveness of risk-adapted colorectal cancer screening: a randomized controlled trial and modeling analysis. [europepmc]
• Navigation activities in an organized colorectal cancer screening program improve follow-up colonoscopy completion. [europepmc]

Related

• Colonoscopy later than 270 days in a fecal immunochemical test-based population screening program is associated with higher prevalence of colorectal cancer
• Colonoscopy and fecal immunochemical testing versus usual care in diagnostic colorectal cancer screening: the SCREESCO randomized controlled trial
• Risk factors and clinical consequences of interval cancers arising within faecal immunochemical testing-based colorectal cancer screening programme
• Single and double faecal immunochemical test strategies are effective in risk stratification for patients with symptoms of per rectal bleeding suggestive of colorectal cancer
• S667 Low Rates of Colonoscopy Follow-Up After Positive Non-Invasive Stool Tests at a Tertiary Care Hospital